<!DOCTYPE html>

<html lang="en">

<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>Biosafety</title>
    <link rel="stylesheet" href="../global/style.css">
    <link rel="stylesheet" href="style.css">
    <link rel="shortcut icon" href="../db/icon.png" type="image/x-icon">
    <script src="https://kit.fontawesome.com/d63d2ac69c.js" crossorigin="anonymous"></script>
</head>

<body>
    <div class="presentation-container">
        <div class="slides-container">
            <!-- Slide 1: Title Slide -->
             <div class="slide active">
                <div class="slide-content">
                    <h1>Biosafety</h1>
                    <div class="highlight-box">
                        <h2 style="border: none">M.Sc. Zoology - Semester 3</h2>
                        <p style="font-size: 1.3em; margin-top: 10px;">Risk Assessment and Management in Biotechnology</p>
                    </div>
                    <div style="text-align: center; margin-top: 40px;">
                        <h3 style="color: var(--primary);">Topics Covered:</h3>
                        <ul style="display: inline-block; text-align: left; font-size: 1.1em;">
                            <li>Biosafety Levels & Containment</li>
                            <li>Risk Assessment Frameworks</li>
                            <li>GMO Regulations & Guidelines</li>
                            <li>Laboratory Safety Protocols</li>
                            <li>Environmental Risk Management</li>
                        </ul>
                    </div>
                    <h2 style="border: none; text-align: center; margin-top: 2rem; color: var(--primary)">Prof. Sunita Arya</h2>
                </div>
            </div>

            <!-- Slide 2: Introduction -->
            <div class="slide">
                <h1>Introduction to Biosafety</h1>
                <div class="slide-content">
                    <div class="definition-box">
                        <strong>Definition:</strong> Biosafety refers to the application of knowledge, techniques, and equipment to prevent personal, laboratory, and environmental exposure to potentially infectious agents or biohazards.
                    </div>

                    <h2>Core Objectives of Biosafety</h2>
                    <ul>
                        <li><strong>Personnel Protection:</strong> Safeguarding laboratory workers and researchers</li>
                        <li><strong>Environmental Protection:</strong> Preventing release of harmful biological agents</li>
                        <li><strong>Community Safety:</strong> Protecting public health from biological risks</li>
                        <li><strong>Research Integrity:</strong> Maintaining quality and reliability of scientific work</li>
                        <li><strong>Regulatory Compliance:</strong> Adhering to national and international guidelines</li>
                    </ul>

                    <div class="highlight-box">
                        <strong>Key Principle:</strong> The precautionary approach - better to prevent than to remediate biological hazards
                    </div>
                </div>
            </div>

            <!-- Slide 3: Biosafety Levels -->
            <div class="slide">
                <h1>Biosafety Levels (BSL)</h1>
                <div class="slide-content">
                    <div class="examples-grid">
                        <div class="example-card">
                            <h4>BSL-1</h4>
                            <p><strong>Risk Level:</strong> Minimal risk to healthy adults</p>
                            <p><strong>Examples:</strong> E. coli K-12, Bacillus subtilis</p>
                            <p><strong>Containment:</strong> Standard microbiological practices</p>
                        </div>

                        <div class="example-card">
                            <h4>BSL-2</h4>
                            <p><strong>Risk Level:</strong> Moderate risk, limited transmission</p>
                            <p><strong>Examples:</strong> Hepatitis B, Salmonella, HIV</p>
                            <p><strong>Containment:</strong> Biological safety cabinets, restricted access</p>
                        </div>

                        <div class="example-card">
                            <h4>BSL-3</h4>
                            <p><strong>Risk Level:</strong> Serious disease, aerosol transmission</p>
                            <p><strong>Examples:</strong> Mycobacterium tuberculosis, SARS-CoV</p>
                            <p><strong>Containment:</strong> Specialized ventilation, sealed laboratory</p>
                        </div>

                        <div class="example-card">
                            <h4>BSL-4</h4>
                            <p><strong>Risk Level:</strong> Extreme danger, high mortality</p>
                            <p><strong>Examples:</strong> Ebola virus, Marburg virus</p>
                            <p><strong>Containment:</strong> Maximum containment, positive-pressure suits</p>
                        </div>
                    </div>

                    <div class="highlight-box">
                        <strong>Selection Criteria:</strong> BSL determined by pathogenicity, mode of transmission, host range, and availability of treatments
                    </div>
                </div>
            </div>

            <!-- Slide 4: Risk Assessment Framework -->
            <div class="slide">
                <h1>Risk Assessment Framework</h1>
                <div class="slide-content">
                    <div class="definition-box">
                        <strong>Risk = Hazard × Exposure × Consequence</strong><br>
                        Systematic evaluation of potential biological hazards and their impact
                    </div>

                    <div style="display: grid; grid-template-columns: 1fr 1fr; gap: 30px;">
                        <div>
                            <h3>Four-Step Process:</h3>
                            <ul>
                                <li><strong>1. Hazard Identification:</strong> What can go wrong?</li>
                                <li><strong>2. Dose-Response Assessment:</strong> How much exposure causes harm?</li>
                                <li><strong>3. Exposure Assessment:</strong> Who is exposed and how?</li>
                                <li><strong>4. Risk Characterization:</strong> What is the overall risk?</li>
                            </ul>

                            <h3>Risk Factors:</h3>
                            <ul>
                                <li>Pathogenicity and virulence</li>
                                <li>Environmental stability</li>
                                <li>Route of transmission</li>
                                <li>Infectious dose</li>
                                <li>Host susceptibility</li>
                            </ul>
                        </div>

                        <div>
                            <h3>Risk Mitigation Strategies:</h3>
                            <ul>
                                <li><strong>Engineering Controls:</strong> Biosafety cabinets, HEPA filtration</li>
                                <li><strong>Administrative Controls:</strong> Training, protocols, access restrictions</li>
                                <li><strong>Personal Protective Equipment:</strong> Gloves, lab coats, respirators</li>
                                <li><strong>Emergency Procedures:</strong> Spill cleanup, exposure protocols</li>
                            </ul>

                            <div class="highlight-box">
                                <strong>Hierarchy of Controls:</strong><br>
                                Elimination > Substitution > Engineering > Administrative > PPE
                            </div>
                        </div>
                    </div>
                </div>
            </div>

            <!-- Slide 5: GMO Regulations -->
            <div class="slide">
                <h1>GMO Regulations & Guidelines</h1>
                <div class="slide-content">
                    <h2>International Frameworks</h2>
                    <div class="examples-grid">
                        <div class="example-card">
                            <h4>Cartagena Protocol</h4>
                            <p><strong>Scope:</strong> International agreement on biosafety of GMOs</p>
                            <p><strong>Key Elements:</strong> Advance Informed Agreement, risk assessment, labeling</p>
                        </div>
                        <div class="example-card">
                            <h4>OECD Guidelines</h4>
                            <p><strong>Scope:</strong> Biotechnology risk assessment and management</p>
                            <p><strong>Principles:</strong> Scientific approach, case-by-case evaluation</p>
                        </div>
                    </div>

                    <h2>Indian Regulatory Framework</h2>
                    <table class="comparison-table">
                        <tr>
                            <th>Authority</th>
                            <th>Role</th>
                            <th>Jurisdiction</th>
                        </tr>
                        <tr>
                            <td>GEAC (Genetic Engineering Appraisal Committee)</td>
                            <td>Environmental release approval</td>
                            <td>Commercial cultivation, import</td>
                        </tr>
                        <tr>
                            <td>RCGM (Review Committee on Genetic Manipulation)</td>
                            <td>Research oversight</td>
                            <td>Laboratory and field trials</td>
                        </tr>
                        <tr>
                            <td>IBSC (Institutional Biosafety Committee)</td>
                            <td>Local oversight</td>
                            <td>Institutional research activities</td>
                        </tr>
                        <tr>
                            <td>State Biotechnology Coordination Committee</td>
                            <td>State-level implementation</td>
                            <td>Regional monitoring</td>
                        </tr>
                    </table>

                    <div class="highlight-box">
                        <strong>Key Principle:</strong> Multi-tier regulatory system ensuring comprehensive oversight from laboratory to environmental release
                    </div>
                </div>
            </div>

            <!-- Slide 6: Laboratory Safety Protocols -->
            <div class="slide">
                <h1>Laboratory Safety Protocols</h1>
                <div class="slide-content">
                    <h2>Standard Microbiological Practices</h2>

                    <div style="display: grid; grid-template-columns: 1fr 1fr; gap: 30px; margin: 20px 0;">
                        <div class="example-card">
                            <h4>Personal Hygiene</h4>
                            <ul>
                                <li>Hand washing before and after work</li>
                                <li>No eating, drinking, or smoking in lab</li>
                                <li>Proper use of personal protective equipment</li>
                                <li>Regular health monitoring</li>
                            </ul>
                        </div>

                        <div class="example-card">
                            <h4>Work Surface Management</h4>
                            <ul>
                                <li>Decontamination before and after use</li>
                                <li>Immediate cleanup of spills</li>
                                <li>Proper waste segregation and disposal</li>
                                <li>Regular equipment maintenance</li>
                            </ul>
                        </div>
                    </div>

                    <h3>Containment Equipment:</h3>
                    <ul>
                        <li><strong>Class I BSC:</strong> Personnel protection, open front</li>
                        <li><strong>Class II BSC:</strong> Personnel and product protection, HEPA filtered</li>
                        <li><strong>Class III BSC:</strong> Maximum containment, glove box design</li>
                        <li><strong>Fume Hoods:</strong> Chemical protection, not for biological agents</li>
                    </ul>

                    <div class="highlight-box">
                        <strong>Emergency Response:</strong> Established procedures for exposures, spills, equipment failures, and medical emergencies are essential
                    </div>
                </div>
            </div>

            <!-- Slide 7: Environmental Risk Assessment -->
            <div class="slide">
                <h1>Environmental Risk Assessment</h1>
                <div class="slide-content">
                    <h2>Key Environmental Concerns</h2>
                    <table class="comparison-table">
                        <tr>
                            <th>Risk Category</th>
                            <th>Potential Impact</th>
                            <th>Assessment Parameters</th>
                        </tr>
                        <tr>
                            <td>Gene Flow</td>
                            <td>Horizontal transfer to wild relatives</td>
                            <td>Sexual compatibility, pollen dispersal</td>
                        </tr>
                        <tr>
                            <td>Non-target Effects</td>
                            <td>Impact on beneficial organisms</td>
                            <td>Toxicity studies, field observations</td>
                        </tr>
                        <tr>
                            <td>Resistance Development</td>
                            <td>Evolution of resistant pests/pathogens</td>
                            <td>Selection pressure, mutation rates</td>
                        </tr>
                        <tr>
                            <td>Biodiversity</td>
                            <td>Ecosystem disruption</td>
                            <td>Community structure, food web analysis</td>
                        </tr>
                    </table>

                    <h2>Assessment Methodology</h2>
                    <div class="examples-grid">
                        <div class="example-card">
                            <h4>Problem Formulation</h4>
                            <p>Define protection goals and assessment endpoints</p>
                            <p>Identify exposure pathways and scenarios</p>
                        </div>
                        <div class="example-card">
                            <h4>Exposure Analysis</h4>
                            <p>Quantify environmental fate and transport</p>
                            <p>Model distribution and persistence</p>
                        </div>
                        <div class="example-card">
                            <h4>Effects Analysis</h4>
                            <p>Laboratory and field studies</p>
                            <p>Dose-response relationships</p>
                        </div>
                    </div>
                </div>
            </div>

            <!-- Slide 8: Waste Management -->
            <div class="slide">
                <h1>Biological Waste Management</h1>
                <div class="slide-content">
                    <h2>Waste Classification System</h2>
                    <div class="examples-grid">
                        <div class="example-card">
                            <h4>Infectious Waste</h4>
                            <p>Cultures, pathological waste, contaminated items</p>
                            <p><strong>Treatment:</strong> Autoclaving, incineration</p>
                        </div>
                        <div class="example-card">
                            <h4>Sharps</h4>
                            <p>Needles, scalpels, broken glassware</p>
                            <p><strong>Treatment:</strong> Puncture-resistant containers, autoclaving</p>
                        </div>
                        <div class="example-card">
                            <h4>Chemically Contaminated</h4>
                            <p>Mixed chemical-biological waste</p>
                            <p><strong>Treatment:</strong> Specialized disposal, not autoclavable</p>
                        </div>
                    </div>

                    <h2>Treatment Technologies</h2>
                    <ul>
                        <li><strong>Steam Sterilization:</strong> 121°C, 15-20 minutes, most common method</li>
                        <li><strong>Chemical Treatment:</strong> Chlorine compounds, aldehydes for liquid waste</li>
                        <li><strong>Incineration:</strong> High-temperature oxidation for pathological waste</li>
                        <li><strong>Irradiation:</strong> Gamma rays or electron beam sterilization</li>
                        <li><strong>Microwave Treatment:</strong> Moist heat with steam injection</li>
                    </ul>

                    <div class="highlight-box">
                        <strong>Waste Minimization:</strong> Reduce, reuse, recycle principles apply - source reduction is the most effective strategy
                    </div>
                </div>
            </div>

            <!-- Slide 9: Institutional Biosafety Committees -->
            <div class="slide">
                <h1>Institutional Biosafety Committees (IBC)</h1>
                <div class="slide-content">
                    <h2>IBC Composition & Responsibilities</h2>
                    <div style="display: grid; grid-template-columns: 1fr 1fr; gap: 30px;">
                        <div>
                            <h3>Mandatory Members:</h3>
                            <ul>
                                <li>Chairperson (senior scientist)</li>
                                <li>Biosafety officer</li>
                                <li>Medical doctor</li>
                                <li>External expert</li>
                                <li>Representative from different disciplines</li>
                                <li>Administrative representative</li>
                            </ul>

                            <h3>Key Functions:</h3>
                            <ul>
                                <li>Review research protocols</li>
                                <li>Approve containment levels</li>
                                <li>Monitor ongoing research</li>
                                <li>Investigate incidents</li>
                                <li>Provide training recommendations</li>
                            </ul>
                        </div>

                        <div>
                            <h3>Review Process:</h3>
                            <ul>
                                <li><strong>Initial Review:</strong> Risk assessment of proposed research</li>
                                <li><strong>Continuing Review:</strong> Annual or periodic evaluation</li>
                                <li><strong>Modification Review:</strong> Changes to approved protocols</li>
                                <li><strong>Incident Review:</strong> Investigation of exposures or accidents</li>
                            </ul>

                            <div class="example-card">
                                <h4>Decision Criteria</h4>
                                <p>Risk level appropriate for containment</p>
                                <p>Adequate personnel training</p>
                                <p>Emergency procedures in place</p>
                                <p>Waste disposal plans adequate</p>
                            </div>
                        </div>
                    </div>

                    <div class="highlight-box">
                        <strong>Regulatory Requirement:</strong> All institutions conducting recombinant DNA research must establish an active IBC
                    </div>
                </div>
            </div>

            <!-- Slide 10: Emerging Biosafety Challenges -->
            <div class="slide">
                <h1>Emerging Biosafety Challenges</h1>
                <div class="slide-content">
                    <h2>New Technologies & Risks</h2>
                    <div class="examples-grid">
                        <div class="example-card">
                            <h4>Gene Editing (CRISPR/Cas)</h4>
                            <p><strong>Challenges:</strong> Off-target effects, gene drives</p>
                            <p><strong>Considerations:</strong> Containment of edited organisms</p>
                        </div>
                        <div class="example-card">
                            <h4>Synthetic Biology</h4>
                            <p><strong>Challenges:</strong> Engineered biological systems</p>
                            <p><strong>Considerations:</strong> Novel risk assessment approaches</p>
                        </div>
                        <div class="example-card">
                            <h4>Gain-of-Function Research</h4>
                            <p><strong>Challenges:</strong> Enhanced pathogen properties</p>
                            <p><strong>Considerations:</strong> Dual-use research oversight</p>
                        </div>
                    </div>

                    <h2>Global Health Security</h2>
                    <ul>
                        <li><strong>Pandemic Preparedness:</strong> Laboratory capacity and surveillance systems</li>
                        <li><strong>Biosecurity:</strong> Preventing misuse of biological research</li>
                        <li><strong>International Cooperation:</strong> Harmonized standards and information sharing</li>
                        <li><strong>Technology Transfer:</strong> Safe dissemination of biotechnology knowledge</li>
                    </ul>

                    <div class="highlight-box">
                        <strong>Future Directions:</strong> Adaptive regulatory frameworks needed to address rapidly evolving biotechnology landscape
                    </div>
                </div>
            </div>

            <!-- Slide 11: Case Studies -->
            <div class="slide">
                <h1>Biosafety Case Studies</h1>
                <div class="slide-content">
                    <h2>Historical Incidents & Lessons Learned</h2>
                    <div class="examples-grid">
                        <div class="example-card">
                            <h4>Anthrax Laboratory Exposures</h4>
                            <p><strong>Incident:</strong> Multiple exposures in research facilities</p>
                            <p><strong>Lesson:</strong> Importance of proper containment and decontamination</p>
                            <p><strong>Impact:</strong> Enhanced BSL-3 requirements</p>
                        </div>
                        <div class="example-card">
                            <h4>SARS Laboratory Outbreaks</h4>
                            <p><strong>Incident:</strong> Secondary infections from lab exposures</p>
                            <p><strong>Lesson:</strong> Adequate training and emergency response critical</p>
                            <p><strong>Impact:</strong> Strengthened oversight of high-risk pathogens</p>
                        </div>
                        <div class="example-card">
                            <h4>StarLink Corn Contamination</h4>
                            <p><strong>Incident:</strong> Unapproved GMO in food supply</p>
                            <p><strong>Lesson:</strong> Need for strict identity preservation systems</p>
                            <p><strong>Impact:</strong> Enhanced monitoring and traceability requirements</p>
                        </div>
                    </div>

                    <h2>Risk Communication Strategies</h2>
                    <ul>
                        <li><strong>Stakeholder Engagement:</strong> Involve communities in decision-making processes</li>
                        <li><strong>Transparent Communication:</strong> Clear explanation of risks and benefits</li>
                        <li><strong>Scientific Literacy:</strong> Education about biotechnology and safety measures</li>
                        <li><strong>Media Relations:</strong> Accurate reporting of biosafety issues</li>
                    </ul>

                    <div class="definition-box">
                        <strong>Key Insight:</strong> Most biosafety incidents result from human error rather than technology failure - emphasizing the importance of training and culture
                    </div>
                </div>
            </div>

            <!-- Slide 12: Summary -->
            <div class="slide">
                <h1>Summary & Future Perspectives</h1>
                <div class="slide-content">
                    <h2>Key Biosafety Principles:</h2>
                    <ul style="font-size: 1.1em;">
                        <li><strong>Risk-Based Approach:</strong> Containment level must match risk assessment</li>
                        <li><strong>Multiple Barriers:</strong> Layered protection systems for comprehensive safety</li>
                        <li><strong>Continuous Monitoring:</strong> Ongoing surveillance and adaptive management</li>
                        <li><strong>Regulatory Compliance:</strong> Adherence to established guidelines and protocols</li>
                        <li><strong>Training & Culture:</strong> Educated personnel and safety-conscious environment</li>
                    </ul>

                    <div class="highlight-box">
                        <h3 style="color: var(--background); border: none; margin: 0;">Emerging Trends in Biosafety</h3>
                        <ul style="color: var(--background); text-align: left; display: inline-block;">
                            <li>Integration of AI in risk assessment</li>
                            <li>Real-time monitoring technologies</li>
                            <li>Harmonized international standards</li>
                            <li>Public participation in decision-making</li>
                            <li>One Health approach integration</li>
                        </ul>
                    </div>

                    <div style="text-align: center; margin-top: 30px;">
                        <h3>Career Opportunities:</h3>
                        <p style="font-size: 1.1em;">Biosafety officers, regulatory affairs specialists, risk assessment consultants, policy advisors, and research scientists</p>
                    </div>

                    <div style="text-align: center; margin-top: 20px; font-style: italic;">
                        <p>"Biosafety is not just about compliance - it's about responsible innovation that protects human health and the environment while advancing scientific knowledge"</p>
                    </div>
                </div>
            </div>
        </div>

        <div class="controls">
            <button class="control-btn interactive3dtilt fa-solid fa-print" id="printBtn" title="Print this slide"></button>
            <button class="control-btn interactive3dtilt fa-solid fa-arrow-left" id="prevBtn" onclick="changeSlide(-1)"></button>
            <span class="slide-counter">
                <span id="currentSlide">1</span> / <span id="totalSlides">12</span>
            </span>
            <button class="control-btn interactive3dtilt fa-solid fa-arrow-right" id="nextBtn" onclick="changeSlide(1)"></button>
            <button class="control-btn interactive3dtilt fa-solid fa-expand" id="fullscreenBtn" title="Toggle fullscreen"></button>
        </div>
    </div>
</body>
<script src="script.js"></script>

</html>